Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Ocular Therapeutix Inc (NASDAQ: OCUL) was $7.84 for the day, down -0.76% from the previous closing price of $7.90. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 0.84 million shares were traded. OCUL stock price reached its highest trading level at $8.15 during the session, while it also had its lowest trading level at $7.81.
Ratios:
Our analysis of OCUL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.94 and its Current Ratio is at 13.01. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.21.
On June 20, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $7 to $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when Heier Jeffrey S. sold 2,948 shares for $9.01 per share. The transaction valued at 26,561 led to the insider holds 269,059 shares of the business.
Kaiser Peter sold 2,897 shares of OCUL for $26,102 on Nov 25 ’24. The Chief Development Officer now owns 213,087 shares after completing the transaction at $9.01 per share. On Nov 25 ’24, another insider, Nayak Sanjay, who serves as the Chief Strategy Officer of the company, sold 1,814 shares for $9.00 each. As a result, the insider received 16,326 and left with 174,380 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1232581248 and an Enterprise Value of 1161941120. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.06 while its Price-to-Book (P/B) ratio in mrq is 3.49. Its current Enterprise Value per Revenue stands at 19.018 whereas that against EBITDA is -10.492.
Stock Price History:
The Beta on a monthly basis for OCUL is 1.22, which has changed by 0.50476193 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, OCUL has reached a high of $11.77, while it has fallen to a 52-week low of $4.06. The 50-Day Moving Average of the stock is -10.42%, while the 200-Day Moving Average is calculated to be -2.87%.
Shares Statistics:
OCUL traded an average of 892.72K shares per day over the past three months and 864910 shares per day over the past ten days. A total of 156.65M shares are outstanding, with a floating share count of 135.64M. Insiders hold about 13.72% of the company’s shares, while institutions hold 75.81% stake in the company. Shares short for OCUL as of 1730332800 were 12671361 with a Short Ratio of 12.50, compared to 1727654400 on 16194368. Therefore, it implies a Short% of Shares Outstanding of 12671361 and a Short% of Float of 8.1599995.
